0001616308-22-000004.txt : 20221019 0001616308-22-000004.hdr.sgml : 20221019 20221018175249 ACCESSION NUMBER: 0001616308-22-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221019 DATE AS OF CHANGE: 20221018 EFFECTIVENESS DATE: 20221019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reiley Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001616308 IRS NUMBER: 471097516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-462121 FILM NUMBER: 221316814 BUSINESS ADDRESS: STREET 1: 3749 BUCHANAN STREET STREET 2: SUITE 475745 CITY: SAN FRANCISCO STATE: CA ZIP: 94147 BUSINESS PHONE: 650 269-8044 MAIL ADDRESS: STREET 1: 3749 BUCHANAN STREET STREET 2: SUITE 475745 CITY: SAN FRANCISCO STATE: CA ZIP: 94147 D/A 1 primary_doc.xml X0708 D/A LIVE 0001616308 Reiley Pharmaceuticals, Inc. 3749 BUCHANAN STREET SUITE 475745 SAN FRANCISCO CA CALIFORNIA 94147 650 269-8044 DELAWARE None None Corporation true B. Michael Silber 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Executive Officer Director Keith Valentine 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Director Jeffrey Dunn 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 Director Pharmaceuticals Decline to Disclose 06b true 0001616308-22-000001 2022-10-12 false true true false 10000 447132 100000 347132 false 2 0 0 0 false Reiley Pharmaceuticals, Inc. B. Michael Silber, Ph.D. B. Michael Silber, Ph.D. CEO 2022-10-18